A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2019
The primary objective of this study is to evaluate the effects of CKD-506 on signs and symptoms of RA in subjects with moderate-to-severe RA who are inadequate responders to methotrexate.
Epistemonikos ID: 133edf0ee361aee919e59f4ea42d3ecfe3d809f1
First added on: Mar 23, 2022